semaglutide dosing vs tirzepatide dose vs. for weight loss—what's the difference? 🤔Both have become very Evaluating Dose Titration in Semaglutide

One glowing Ro review on Reddit notes that the educational content is interesting and insightful, the team is "responsive, helpful, and flexible, and the service is fast

Focusing specifically on Mounjaro, a 2025 study in adults with type 1 diabetes and overweight or obesity found that after 21 months, participants experienced 23% weight loss, sustained improvements in glucose management, and significant improvements in blood pressure, cholesterol, triglycerides , and eGFR (a marker of kidney function)

CagriSema is filed for approval and represents Novo Nordisk's competitive response

Food and Drug Administration (2024) Compounding and the FDA: Questions and answers, Food and Drug Administration (2024) Zepbound, DailyMed (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food and Drug Administration (2024) FDA warns patients and health care professionals not to use compounded drugs from Fullerton Wellness, Food and Drug Administration (2024) An open letter from Eli Lilly and Company regarding certain practices related to Mounjaro and Zepbound, Eli Lilly and Company (2024) Compounding when drugs are on FDAs drug shortages list, Food and Drug Administration (2024) Human drug compounding, Food and Drug Administration (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice